Topic: How To Invest

Dividend Advisor Hotline – Thursday, April 1, 2021

Article Excerpt

PFIZER INC., $36.30, New York symbol PFE, is a top pick for 2021. The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia) and Enbrel (rheumatoid arthritis). With the March 2021 payment, Pfizer raised your dividend by 2.6%. Investors now receive $0.39 a share instead of $0.38. The new annual rate of $1.56 yields a high 4.3%. In December 2020, the company began shipping its two-shot COVID-19 vaccine, which it developed in partnership with German drugmaker BioNTech (Nasdaq symbol BNTX). Pfizer expects the COVID-19 vaccine will account for $15 billion (or about 25%) of its total projected 2021 revenue of between $59.4 billion and $61.4 billion. The partners now expect to produce 2.5 billion doses in 2021, up from their earlier forecast of between 2.3 billion and 2.4 billion doses. Separately, Pfizer is now testing an oral treatment for COVID-19. Administering a pill at the first sign of infection should help the patient…